Showing results (1091-1100 of 3,153) with videos related to

Sort By:
Pageof 316
Neuro-Oncology|August 30, 2024
Analysis of HER2 expression changes from breast primary to brain metastases and the impact of HER2-low expression on overall survivalAlyssa M Pereslete, Melissa E Hughes, Alyssa R Martin, et al.
Neuro-Oncology|August 10, 2024
Immune landscape of isocitrate dehydrogenase-stratified primary and recurrent human gliomasPravesh Gupta, Minghao Dang, Shivangi Oberai, et al.
Neuro-Oncology|August 16, 2024
The emerging field of viroimmunotherapy for pediatric brain tumorsMarc Garcia-Moure, Virginia Laspidea, Sumit Gupta, et al.
Neuro-Oncology|June 26, 2024
Medulloblastoma in children with Fanconi anemia: Association with FA-D1/FA-N, SHH type and poor survival independent of treatment strategiesMarthe Sönksen, Denise Obrecht-Sturm, Pablo Hernáiz Driever, et al.
Neuro-Oncology|May 27, 2006
Treatment-related myelodysplasia/AML in a patient with a history of breast cancer and an oligodendroglioma treated with temozolomide: case study and review of the literatureVanita Noronha, Nancy Berliner, Karen K Ballen, et al.
Neuro-Oncology|March 15, 2006
Validation of neuroradiologic response assessment in gliomas: measurement by RECIST, two-dimensional, computer-assisted tumor area, and computer-assisted tumor volume methodsEvanthia Galanis, Jan C Buckner, Matthew J Maurer, et al.
Neuro-Oncology|March 15, 2006
Quality of health information on the Internet in pediatric neuro-oncologyDarren R Hargrave, Ursula A Hargrave, Eric Bouffet
Neuro-Oncology|June 16, 2006
Therapeutic implications of tumor interstitial fluid pressure in subcutaneous RG-2 tumorsYot Navalitloha, Erica S Schwartz, Elizabeth N Groothuis, et al.
Neuro-Oncology|October 5, 2006
Convection-enhanced delivery of a topoisomerase I inhibitor (nanoliposomal topotecan) and a topoisomerase II inhibitor (pegylated liposomal doxorubicin) in intracranial brain tumor xenograftsYoji Yamashita, Michal T Krauze, Tomohiro Kawaguchi, et al.
Neuro-Oncology|October 5, 2006
Hypersomnia as presenting symptom of anti-Ma2-associated encephalitis: case studyIñigo Rojas-Marcos, Francesc Graus, Gema Sanz, et al.
Pageof 316